Beroctocog alfa
- Generic Name
- Beroctocog alfa
- Brand Names
- Alphanate
- Drug Type
- Biotech
- CAS Number
- 9001-27-8
- Unique Ingredient Identifier
- 17RNR4H479
Overview
No overview information available.
Background
No background information available.
Indication
Beroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in adult and pediatric patients with von Willebrand Disease in who desmopression is either ineffective or contraindicated. It is not indicated for patients with severe (i.e. type 3) von Willebrand Disease whom are undergoing major surgery.
Associated Conditions
- Bleeding
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
ALPHANATE FOR INJECTION 500 iu/vial
Manufacturer:GRIFOLS BIOLOGICALS LLC., INSTITUTO GRIFOLS, S.A. (manufacturer for WFI), ROVI PHARMA INDUSTRIAL SERVICES, S.A. (alternate manufacturer for WFI), Grifols Therapeutics Inc. (Alternate Manufacturer for Cryoprecipitate)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:500 iu/vial
Online:Yes
Approved: 1996/11/28
Approval:SIN09032P
ALPHANATE FOR INJECTION 1000 iu/vial
Manufacturer:GRIFOLS BIOLOGICALS LLC., INSTITUTO GRIFOLS, S.A. (manufacturer for WFI), ROVI PHARMA INDUSTRIAL SERVICES, S.A. (alternate manufacturer for WFI), Grifols Therapeutics Inc. (Alternative Manufacturer for Cryoprecipitate
Form:INJECTION, POWDER, FOR SOLUTION
Strength:1000 iu/vial
Online:Yes
Approved: 1996/11/28
Approval:SIN09030P
Optivate
Manufacturer:Bio Products Laboratory, Pharma Hameln GmbH (Diluent), BCM LTD (Diluent), B Braun melsingen AG (Diluent)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:100 iu/ml
Online:Yes
Approved: 2006/03/16
Approval:SIN13191P
ALPHANATE FOR INJECTION 250 iu/vial
Manufacturer:GRIFOLS BIOLOGICALS LLC., INSTITUTO GRIFOLS, S.A. (manufacturer for WFI), ROVI PHARMA INDUSTRIAL SERVICES, S.A. (alternate manufacturer for WFI), Grifols Therapeutics Inc (Alternate Manufacturer for Cryoprecipitate)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:250 iu/vial
Online:Yes
Approved: 1996/11/28
Approval:SIN09031P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath